Improvement in itch and other psoriasis symptoms with brodalumab in phase 3 randomized controlled trials
Journal of the European Academy of Dermatology and Venereology | Jun 14, 2018
Patient-reported symptoms and signs of moderate-to-severe psoriasis treated with guselkumab or adalimumab: Results from the randomized VOYAGE 1 trial
Journal of the European Academy of Dermatology and Venereology | Jun 13, 2018
Risk of developing pressure sore in amyotrophic lateral sclerosis patients – A nationwide cohort study
Journal of the European Academy of Dermatology and Venereology | Jun 13, 2018
Most read this week